Advanced search
Publication Cover
Nutrition and Cancer Volume 70, 2018 - Issue 2
Submit an article Journal homepage
118
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Anemia in Cutaneous Malignant Melanoma: Low Blood Hemoglobin Level is Associated with Nodal Involvement, Metastatic Disease, and Worse Survival

Faruk TasInstitute of Oncology, University of Istanbul, Istanbul, TurkeyCorrespondence[email protected]
&
Kayhan ErturkInstitute of Oncology, University of Istanbul, Istanbul, TurkeyORCID Iconhttp://orcid.org/0000-0001-5804-6800
ORCID Icon
Pages 236-240 | Received 13 Mar 2017, Accepted 23 Aug 2017, Published online: 21 Dec 2017

References

  • Tas F, Eralp Y, Basaran M, Sakar B, Alici S, et al.: Anemia in oncology practice: Relation to diseases and their therapies. Am J Clin Oncol 25, 371–379, 2002. doi:10.1097/00000421-200208000-00011.
  • Knight K, Wade S, and Balducci L: Prevalence and outcomes of anaemia in cancer: A systematic review of the literature. Am J Med 116( Suppl 7A), 11S–26S, 2004. doi:10.1016/j.amjmed.2003.12.008.
  • Dicato M, Plawny L, and Diederich M: Anemia in cancer. Ann Oncol 21( Suppl 7), vii167–vii172, 2010.
  • Caro JJ, Salas M, Ward A, and Goss G: Anemia as an independant prognostic factor for survival in patients with cancer: A systematic, quantitative review. Cancer 91, 2214–2221, 2001. doi:10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P.
  • Zhang YJ, Chen YY, Chen DT, Jiang Y, Huang W, et al.: Impact of preoperative anemia on relapse and survival in breast cancer patients. BMC Cancer 14, 844, 2014. doi:10.1186/1471-2407-14-844.
  • Aoe K, Hiraki A, Maeda T, Katayama H, Fujiwara K, et al.: Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer. Intern Med 44, 800–804, 2005. doi:10.2169/internalmedicine.44.800.
  • An MS, Yoo JH, Kim KH, Bae KB, Choi CS, et al.: T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy. World J Surg Oncol 13, 64, 2015. doi:10.1186/s12957-015-0488-7.
  • Lim S, Lee CM, Park JM, Jung SY, and Lee KB: An association between preoperative anemia and poor prognostic factors and decreased survival in early stage cervical cancer patients. Obstet Gynecol Sci 57, 471–477, 2014. doi:10.5468/ogs.2014.57.6.471.
  • Huang J, Feldman AS, Dong L, Cornejo K, Liu Q, et al.: Preoperative anemia as an independent prognostic indicator of papillary renal cell carcinoma. Clin Genitourin Cancer 13, e353–60, 2015. doi:10.1016/j.clgc.2015.04.014.
  • Szkandera J, Gerger A, Liegl-Atzwanger B, Stotz, SH, Ploner F, et al.: Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients. PLoS One 9(9), e107297, 2014. doi:10.1371/journal.pone.0107297.
  • Guo SS, Tang LQ, Chen QY, Zhang L, Liu LT, et al.: Is hemoglobin level in patients with nasopharyngeal carcinoma still a significant prognostic factor in the era of intensity-modulated radiotherapy technology? PLoS One 10(8), e0136033, 2015. doi:10.1371/journal.pone.0136033.
  • Tas F, Oguz H, Argon A, Duranyildiz D, Camlica H, et al.: The value of serum levels of IL-6, TNF-alpha and erythropoietin in metastatic malignant melanoma: serum IL-6 level is valuable prognostic factor at least as serum LDH in advanced melanoma. Med Oncol 22, 241–246, 2005. doi:10.1385/MO:22:3:241.
  • Tas F, Karabulut S, Yasasever CT, and Duranyildiz D: Clinical significance of serum fibronectin and vitronectin levels in melanoma patients. Melanoma Res 24, 475–479, 2014. doi:10.1097/CMR.0000000000000107.
  • Tas F, Bilgin E, Erturk K, and Duranyildiz D: Clinical significance of serum claudin-1 levels in melanoma patients. Melanoma Res 26, 377–381, 2016. doi:10.1097/CMR.0000000000000241.
  • Tas F, Ciftci R, Kilic L, Bilgin E, Keskin S, et al.: Clinical and prognostic significance of coagulation assays in melanoma. Melanoma Res 22, 368–375, 2012. doi:10.1097/CMR.0b013e328357be7c.
  • Tas F, Karabulut S, Serilmez M, Yildiz I, Sen F, et al.: Clinical significance of serum M30 and M65 levels in melanoma. Melanoma Res 23, 390–395, 2013. doi:10.1097/CMR.0b013e328363e4ab.
  • Ozguroglu M, Arun B, Demir G, Demirelli F, Mandel NM, et al.: Serum erythropoietin level in anemic cancer patients. Med Oncol 17, 29–34, 2000. doi:10.1007/BF02826213.
  • Lee AS, Kim DH, Lee JE, Jung YJ, Kang KP, et al.: Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis. Cancer Res 71, 4506–4517, 2011. doi:10.1158/0008-5472.CAN-10-3787.
  • Mirmohammadsadegh A, Marini A, Gustrau A, Delia D, Nambiar S, et al.: Role of erythropoietin receptor expression in malignant melanoma. J Invest Dermatol 130, 201–210, 2010. doi:10.1038/jid.2009.162.
  • Kumar SM, Zhang G, Bastian BC, Arcasoy MO, Karande P, et al.: Erythropoietin receptor contributes to melanoma cell survival in vivo. Oncogene 31, 1649–1660, 2012. doi:10.1038/onc.2011.366.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.